CIK 0001856725
- Emerging growth company
Rani Therapeutics Holdings, Inc.
Sign in to watch- Ticker
- RANI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 863114789
- Phone
- +1 408-457-3700
- Business address
- 47709 FREMONT BLVD, FREMONT, CA, 94538
- 4 Conversion Director acquired 7,694 shares (conversion)
- 4 Conversion Director acquired 7,694 shares (conversion)
- 4 Open-market sale Director sold 80,252 shares at an average $10.64 ($853,672)
- 4 Open-market sale Director sold 80,252 shares at an average $10.64 ($853,672)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Executive Officer acquired 86,600 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 32,900 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 41,200 shares (grant or award)
- 4 Grant or award General Counsel acquired 24,500 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Conversion Director acquired 2,309,490 shares (conversion)
- 4 Conversion Director acquired 2,309,490 shares (conversion)
- 4 Other disposition Chief Executive Officer disposed of 827,467 shares (other)
Page 8 of 10 · 194 filings